ArticleMedicina (Kaunas, Lithuania)2022

Adverse Reaction Profiles Related to Gastrointestinal Bleeding Events Associated with BCR-ABL Tyrosine Kinase Inhibitors.

Kei Kawada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.